MicrobiologybioRxivPreprint
Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants
J. A. Duty, T. A. Kraus, H. Zhou…·R. Allen
This paper identifies a broadly neutralizing antibody, STI-9167, effective against SARS-CoV-2 variants including Omicron and Omicron + R346K, and describes its development for clinical trials.
DOI 10.1101/2022.01.19.476998